Liminatus Pharma (LIMN) Stock Analysis: AI Score & Alternative Data
LIMN alt-data: sentiment climbing, web traffic lagging
Is Liminatus Pharma a buy right now? The alternative data says hold. This LIMN stock analysis is built on the 25+ alternative data signals AltIndex tracks on Liminatus Pharma every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 48/100: a Hold. The stock trades at $3.26 with a $5M market cap.
The bullish side of the 90-day ledger: sentiment up 22.0% to 100/100. The drag: web traffic down 84.1% to 221 monthly visits. That tension is what keeps the score mid-range.
Every signal links to its own page with full history, the LIMN technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on LIMN is just below.
Liminatus Pharma AI Stock Analysis
Liminatus Pharma is a cutting-edge biopharmaceutical company specializing in the development and commercialization of innovative therapeutics. The company's primary focus is on novel treatments for various diseases, leveraging advanced research and development technologies to bring new solutions to market.
Analysis generated October 2, 2026.
Recent Liminatus Pharma Stock Alerts
|
Liminatus Pharma | October 12 Price is down by -6.7% in the last 24h. |
|
Liminatus Pharma | October 8 Price is down by -6.4% in the last 24h. |
|
Liminatus Pharma | October 6 Price is down by -6.8% in the last 24h. |
|
Liminatus Pharma | September 29 Price is down by -6.1% in the last 24h. |
Liminatus Pharma Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 221 | 84.1% | |
| Sentiment | 100 | 22.0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 70 | N/A | |
| Stocktwits Mentions | 4 | 99.7% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 2K | N/A |
About Liminatus Pharma (LIMN)
Liminatus Pharma, Inc. is a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is headquartered in LA Palma, California.
| Price | $3.26 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $5M |
| Year Range | $3 – $103 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Biotechnology |
Latest Liminatus Pharma News
View more →
LunR Royalties initiated with bullish view at Jefferies, here's whyAugust 20 - Thefly.com |
See Liminatus Pharma’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for LIMN, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREELiminatus Pharma Earnings & Financial Performance
View all earnings →Liminatus Pharma Insider Trading Activity
View all →| No recent insider transactions on file. |
Liminatus Pharma Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to Liminatus Pharma
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
XTL BiopharmaceuticalsXTLB |
$1.91 1.6% | $5M | 48 |
 |
Processa PharmaPCSA |
$1.67 3.1% | $5M | 46 |
 |
Jupiter NeurosciencesJUNS |
$3.09 3.1% | $4M | 50 |
 |
Enlivex TherapeuticsENLV |
$0.22 1.6% | $4M | 45 |
 |
Galmed PharmaceuticalsGLMD |
$4.63 21.1% | $5M | 60 |
Explore Liminatus Pharma Data
Frequently Asked Questions: Liminatus Pharma (LIMN)
Liminatus Pharma has an AltIndex AI Score of 48/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
48/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Liminatus Pharma (LIMN) stock is $3.26 with a market cap of $5M.
As of today, Liminatus Pharma’s PE (Price to Earnings) ratio is —.
View the latest Liminatus Pharma insider transactions to see recent buying and selling activity by company executives and directors.
Check the Liminatus Pharma congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The LIMN stock price chart above shows Liminatus Pharma’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Liminatus Pharma technical analysis for RSI, moving averages, and more.
See the stocks similar to Liminatus Pharma section on this page for companies in the same industry ranked by market cap and AI Score.
